Trial Details

TERMINATED
Basic Information
Clinical ID c957
Identifier NCT04074590
Trial Title Study of Efficacy, Safety, and Tolerability of LYS006, in Patients With Mild to Moderate Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Colitis, Ulcerative
Interventions DRUG: LYS006|DRUG: Placebo
Participant Information
Sponsor Novartis Pharmaceuticals
City Sofia
Country/Region Bulgaria
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2020-02-03
Primary Completion Date 2022-11-07
Completion Date 2022-11-07